Article
Expanded approval for daratumumab in multiple myeloma
- Author:
- FACP; report prepared by Jane de Lartigue
Publish date: August 2, 2018
Article
Ribociclib: another CDK inhibitor hits the mark in breast cancer
- Author:
- FACP; report prepared by Jane de Lartigue
Publish date: August 20, 2017
Article
Approval makes olaratumab the first first-line treatment option for soft tissue sarcoma in more than 40 years
- Author:
- FACP; report prepared by Jane de Lartigue
Publish date: August 20, 2017
Article
Rucaparib – second PARP inhibitor hits the market for ovarian cancer
- Author:
- FACP; report prepared by Jane de Lartigue
Publish date: May 17, 2017
Article
Pembrolizumab is the first immune checkpoint inhibitor to receive approval for head and neck cancer
- Author:
- FACP; report prepared by Jane de Lartigue
Publish date: December 22, 2016
Article
Fourth approved indication for ofatumumab in chronic lymphocytic leukemia
- Author:
- FACP; report prepared by Jane de Lartigue
Publish date: November 22, 2016
Article
Renal cell carcinoma approval adds another notch to cabozantinib’s belt
- Author:
- FACP; report prepared by Jane de Lartigue
Publish date: November 21, 2016
Article
Alectinib provides a new option for ALK-positive NSCLC patients after progression on crizotinib
- Author:
- FACP; report prepared by Jane de Lartigue
Publish date: June 29, 2016
Article
Panobinostat: a novel mechanism of action shows promise in multiple myeloma
- Author:
- FACP; report prepared by Jane de Lartigue
Publish date: August 25, 2015